[
  {
    "ticker": "TOR",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02976861",
    "id": "02976861",
    "pages": 17,
    "price_sensitive": true,
    "date": "20250805",
    "time": "0840",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250805/pdf/06mjqjwmyrnl9b.pdf",
    "summary": "<h3><strong>Material Information Summary</strong></h3>\n<h4><strong>Exploration Results Announcement</strong></h4>\n<ul>\n<li><strong>Key Drill Intercept:</strong>  </li>\n<li><strong>25PRCDD206:</strong> 15.5m @ 12 g/t Au (incl. 8.5m @ 20.8 g/t Au) within 54.2m @ 3.7 g/t Au at ~380m vertical depth.  </li>\n<li><strong>Conductor Plates (DHEM):</strong>  </li>\n<li>15 plates identified, validating conductivity-gold correlation.  </li>\n<li><strong>C9 (100m x 80m) &amp; C13 (80m x 80m)</strong> extend mineralization ~50m west, suggesting resource upside.  </li>\n<li><strong>Untested northern (C10, C11) and southern (C14, C15) plates</strong> indicate expansion potential beyond current MRE.  </li>\n<li><strong>Mineralized Corridor:</strong>  </li>\n<li>Plates C1, C8, C9, C12, C13 define a <strong>~240m strike-length corridor</strong>, open at depth and along strike.  </li>\n<li><strong>Metallurgy:</strong>  </li>\n<li>Gold recoveries <strong>90.9\u201399.7%</strong> (gravity + CIL); low reagent consumption.  </li>\n<li><strong>Resource Context:</strong>  </li>\n<li>Current MRE: <strong>250koz Au @ 3.1 g/t</strong> (open in multiple directions).  </li>\n</ul>\n<p><strong>No material capital markets actions (e.g., raising, trading halt) identified.</strong></p>",
    "usage": {
      "prompt_tokens": 9433,
      "completion_tokens": 306,
      "total_tokens": 9739,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-08-04T22:45:30.937903"
  },
  {
    "ticker": "CDA",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02976859",
    "id": "02976859",
    "pages": 1,
    "price_sensitive": false,
    "date": "20250805",
    "time": "0838",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250805/pdf/06mjqdbkf2hy2l.pdf",
    "summary": "<p><strong>No material information identified</strong>  </p>\n<p>(Note: The announcement only provides a date for FY25 results release and details of a webinar, with no financial data, guidance, or material updates.)</p>",
    "usage": {
      "prompt_tokens": 466,
      "completion_tokens": 39,
      "total_tokens": 505,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-08-04T22:50:21.059740"
  },
  {
    "ticker": "CBA",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02976858",
    "id": "02976858",
    "pages": 10,
    "price_sensitive": false,
    "date": "20250805",
    "time": "0838",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250805/pdf/06mjqb75f5g44t.pdf",
    "summary": "<h3><strong>Material Information Summary - CBA Financial Reporting Update (5 August 2025)</strong></h3>\n<h4><strong>Key Points:</strong></h4>\n<ol>\n<li><strong>Notable Expenses in 2H25:</strong>  </li>\n<li>\n<p><strong>$130M pre-tax provisions</strong> ($45M Bankwest restructuring, $52M domestic remediation, $33M ASB remediation). Excluded from underlying expenses.  </p>\n</li>\n<li>\n<p><strong>Loan Portfolio Updates (30 Jun 2024):</strong>  </p>\n</li>\n<li><strong>Gross loans:</strong> $949.9B (+2.9% vs. Dec-24).  </li>\n<li><strong>Non-performing exposures (NPEs):</strong> $10.3B (up from $9.6B in Jun-24).  </li>\n<li>\n<p><strong>Stage 3 (high-risk) loans:</strong> $9.6B (5.3% of business/corporate loans).  </p>\n</li>\n<li>\n<p><strong>Disclosure Changes:</strong>  </p>\n</li>\n<li>\n<p>Aligned with APRA\u2019s revised <strong>APS 330</strong> (Pillar 3) and <strong>APS 220</strong> (credit risk). Enhanced past-due loan aging categories and NPE movement breakdowns.  </p>\n</li>\n<li>\n<p><strong>Upcoming Catalyst:</strong>  </p>\n</li>\n<li><strong>FY25 Results Announcement:</strong> Scheduled for <strong>13 August 2025</strong>.  </li>\n</ol>\n<h4><strong>Omitted:</strong> Minor formatting changes, director names, and non-material operational details.</h4>\n<p><strong>Brevity Note:</strong> Focused on impacts to financials, risk exposure, and regulatory compliance. No capital raising, dividends, or trading halt triggers identified.</p>",
    "usage": {
      "prompt_tokens": 5350,
      "completion_tokens": 308,
      "total_tokens": 5658,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-08-04T22:47:34.904883"
  },
  {
    "ticker": "BKI",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02976860",
    "id": "02976860",
    "pages": 2,
    "price_sensitive": false,
    "date": "20250805",
    "time": "0838",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250805/pdf/06mjqggh7fvnq6.pdf",
    "summary": "<h3><strong>Material Information Summary</strong></h3>\n<h4><strong>Financial &amp; Operational Highlights</strong></h4>\n<ul>\n<li><strong>Pre-Tax NTA</strong>: Reached <strong>$2.00 per share</strong> (first time) as of July 2025.  </li>\n<li><strong>Total Shareholder Return (TSR)</strong>:  </li>\n<li><strong>July 2025</strong>: +7.7% (outperforming index by <strong>5.3%</strong>).  </li>\n<li><strong>FY25 (YTD)</strong>: +14.3% incl. franking (vs. index\u2019s +13.4%).  </li>\n<li><strong>Dividend</strong>: Final dividend of <strong>4.00cps</strong>, bringing FY2025 total to <strong>7.90cps</strong> (+1% YoY).  </li>\n<li><strong>Ex-date</strong>: 5 Aug 2025 | <strong>Record date</strong>: 6 Aug 2025 | <strong>Payment date</strong>: 28 Aug 2025.  </li>\n<li><strong>Grossed-up yield</strong>: <strong>6.0%</strong> (based on $1.89 share price).  </li>\n<li><strong>Portfolio Performance</strong>:  </li>\n<li>July return: <strong>+2.0%</strong>.  </li>\n<li>Top performers: <strong>New Hope (+13%)</strong>, <strong>Woodside (+13%)</strong>, <strong>Yancoal (+10%)</strong>, <strong>BHP (+7%)</strong>.  </li>\n</ul>\n<h4><strong>Capital &amp; Liquidity</strong></h4>\n<ul>\n<li><strong>Market Cap</strong>: <strong>$1,525m</strong>.  </li>\n<li><strong>Cash</strong>: <strong>$109m</strong> (6.7% of portfolio).  </li>\n<li><strong>Debt</strong>: <strong>$0</strong>.  </li>\n<li><strong>Management Fee</strong>: <strong>0.10%</strong>.  </li>\n</ul>\n<h4><strong>Key Portfolio Exposures</strong></h4>\n<ul>\n<li>Top holdings: <strong>CBA (9.6%)</strong>, <strong>NAB (7.2%)</strong>, <strong>BHP (6.4%)</strong>, <strong>Wesfarmers (5.1%)</strong>.  </li>\n<li>Sector leaders: <strong>Energy</strong> (+13% for key holdings), <strong>Healthcare</strong> (Ramsay, Sonic contributions).  </li>\n</ul>\n<p><strong>No material changes to capital structure or liquidity events identified.</strong></p>",
    "usage": {
      "prompt_tokens": 2449,
      "completion_tokens": 417,
      "total_tokens": 2866,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-08-04T22:45:19.323912"
  },
  {
    "ticker": "ALL",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02976857",
    "id": "02976857",
    "pages": 6,
    "price_sensitive": false,
    "date": "20250805",
    "time": "0836",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250805/pdf/06mjq7w6q5bx98.pdf",
    "summary": "<ul>\n<li><strong>Buy-back Type</strong>: On-market buy-back  </li>\n<li><strong>Total Buy-back Program Size</strong>: Up to $750 million AUD  </li>\n<li><strong>Buy-back Period</strong>: 7/3/2025 to 6/3/2026  </li>\n<li><strong>Securities Bought Back (Previous Day)</strong>: 92,375 shares  </li>\n<li><strong>Total Consideration Paid (Previous Day)</strong>: $6,342,433.79 AUD  </li>\n<li><strong>Price Range (Previous Day)</strong>: $68.23 AUD (low) to $69.00 AUD (high)  </li>\n<li><strong>Total Buy-back to Date</strong>: 4,103,911 shares ($268.87 million AUD)  </li>\n<li><strong>Broker</strong>: Barrenjoey Markets Pty Limited  </li>\n</ul>\n<p>No material changes to capital structure or valuation impact beyond ongoing buy-back execution.</p>",
    "usage": {
      "prompt_tokens": 1519,
      "completion_tokens": 166,
      "total_tokens": 1685,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-08-04T22:56:32.849693"
  },
  {
    "ticker": "EOS",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02976854",
    "id": "02976854",
    "pages": 2,
    "price_sensitive": true,
    "date": "20250805",
    "time": "0835",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250805/pdf/06mjq1dq98j2md.pdf",
    "summary": "<ul>\n<li><strong>Order Announcement</strong>: Secured \u20ac71.4M (~A$125M) order for a 100kW high-power laser counter-drone system from a European NATO member state.  </li>\n<li><strong>Delivery Timeline</strong>: Production and delivery scheduled for 2025\u20132028 from Singapore.  </li>\n<li><strong>Strategic Significance</strong>: First global export order for a 100kW-class laser defense system, reinforcing EOS's leadership in counter-drone technology.  </li>\n</ul>\n<p><em>Omitted: Customer identity (deemed non-material), operational details without direct financial/trading impact.</em></p>",
    "usage": {
      "prompt_tokens": 1177,
      "completion_tokens": 113,
      "total_tokens": 1290,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-08-04T22:43:11.153317"
  },
  {
    "ticker": "FFM",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02976855",
    "id": "02976855",
    "pages": 28,
    "price_sensitive": true,
    "date": "20250805",
    "time": "0835",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250805/pdf/06mjq3h151tkbb.pdf",
    "summary": "<h3><strong>Material Information Summary (ASX: FFM Announcement)</strong></h3>\n<h4><strong>1. Metallurgical Results &amp; Project Development</strong></h4>\n<ul>\n<li><strong>Exceptional recoveries</strong>: Copper (&gt;98%), Gold (&gt;85%), Silver (&gt;84%) from Ming Mine mineralization.  </li>\n<li><strong>Scoping Study</strong>: Expected completion in Q1 2026.  </li>\n<li><strong>Environmental approval secured</strong> for processing plant; construction permitting underway.  </li>\n</ul>\n<h4><strong>2. Capital Raising &amp; Financial Position</strong></h4>\n<ul>\n<li><strong>Total funding</strong>: ~A$145M (as of 30 June 2025 + SPP proceeds + pending T2 Placement).  </li>\n<li><strong>T2 Placement</strong>: A$26.6M subject to shareholder approval (GM on 28 August 2025).  </li>\n</ul>\n<h4><strong>3. Mineral Resource Estimate (Green Bay Project)</strong></h4>\n<ul>\n<li><strong>Measured &amp; Indicated</strong>: 24.4Mt @ 1.7% Cu, 0.3g/t Au (199koz Au).  </li>\n<li><strong>Inferred</strong>: 34.6Mt @ 1.7% Cu, 0.3g/t Au (348koz Au).  </li>\n<li><strong>Contained gold</strong>: 550koz across all categories.  </li>\n</ul>\n<h4><strong>4. Operational Highlights</strong></h4>\n<ul>\n<li><strong>8 rigs drilling</strong>: Focus on resource expansion (4 infill, 2 step-out) and regional targets.  </li>\n<li><strong>MRE update</strong>: Planned for Q4 2025 to support Scoping Study.  </li>\n<li><strong>Processing design</strong>: Simple crush-grind-flotation flow sheet; low power/consumable costs (Bond Work Index: 10.4\u201311.4 kWh/t).  </li>\n</ul>\n<h4><strong>5. Key Upcoming Milestones</strong></h4>\n<ul>\n<li><strong>Scoping Study</strong>: Q1 2026.  </li>\n<li><strong>Shareholder vote on T2 Placement</strong>: 28 August 2025.  </li>\n</ul>\n<p><strong>Note</strong>: Omits routine operational/background details. Focused on valuation, liquidity, and capital structure impacts.</p>",
    "usage": {
      "prompt_tokens": 19065,
      "completion_tokens": 402,
      "total_tokens": 19467,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-08-04T22:53:07.928300"
  },
  {
    "ticker": "TIP",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02976853",
    "id": "02976853",
    "pages": 6,
    "price_sensitive": false,
    "date": "20250805",
    "time": "0835",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250805/pdf/06mjpz9vzksv13.pdf",
    "summary": "<p><strong>Summary of ASX Announcement - TEAMINVEST PRIVATE GROUP LIMITED (TIP):</strong>  </p>\n<ul>\n<li><strong>Type:</strong> On-market share buy-back update (daily notification)  </li>\n<li><strong>Buy-back details:</strong>  </li>\n<li><strong>Total shares bought back (cumulative):</strong> 79,477  </li>\n<li><strong>Shares bought back on previous day (4/8/2025):</strong> 5,714  </li>\n<li><strong>Total consideration paid (previous day):</strong> AUD 9,999.50  </li>\n<li><strong>Price range (previous day):</strong> AUD 1.75 (fixed, no variance)  </li>\n<li><strong>Remaining buy-back quota:</strong> 2,614,892 shares (out of max 2,700,083)  </li>\n<li><strong>Buy-back period:</strong> 14 April 2025 to 14 April 2026 (extended for 12 months).  </li>\n</ul>\n<p><em>No other material information identified.</em></p>",
    "usage": {
      "prompt_tokens": 1529,
      "completion_tokens": 189,
      "total_tokens": 1718,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-08-04T22:56:46.164388"
  },
  {
    "ticker": "PIX",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02976852",
    "id": "02976852",
    "pages": 3,
    "price_sensitive": true,
    "date": "20250805",
    "time": "0834",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250805/pdf/06mjpx49pqzcx7.pdf",
    "summary": "<h3>Material Information Summary:</h3>\n<ul>\n<li><strong>Scheme Withdrawal</strong>  </li>\n<li>Platinum Capital withdraws proposed scheme of arrangement with Platinum International Fund Complex ETF (PIXX) due to insufficient shareholder support (requires 75% approval).  </li>\n<li>\n<p>L1 Capital (holding ~17% stake) opposes the scheme; court meeting scheduled for 12 August 2025 to be canceled.  </p>\n</li>\n<li>\n<p><strong>On-Market Buy-Back Approval</strong>  </p>\n</li>\n<li>General meeting on <strong>12 August 2025</strong> proceeds to approve an on-market buy-back of up to <strong>20% of shares</strong> (previously 50% if scheme failed).  </li>\n<li>\n<p>L1 Capital will vote in favor of the buy-back. Board unanimously recommends approval.  </p>\n</li>\n<li>\n<p><strong>L1 Capital\u2019s Non-Binding Proposal &amp; Board Changes</strong>  </p>\n</li>\n<li>L1 Capital proposes replacing Platinum\u2019s management with its own <strong>Global Long Short strategy</strong>, subject to shareholder approval.  </li>\n<li>\n<p>Requisitioned EGM to appoint three new directors (Rachel Grimes, David Gray, Douglas Farrell). If elected, two current directors (Margaret Towers, Ian Hunter) will resign.  </p>\n</li>\n<li>\n<p><strong>Key Dates</strong>  </p>\n</li>\n<li><strong>General Meeting</strong>: 12 August 2025 (buy-back vote).  </li>\n<li><strong>EGM for Board Changes</strong>: Date to be announced.  </li>\n</ul>\n<p>No other material information identified.</p>",
    "usage": {
      "prompt_tokens": 2353,
      "completion_tokens": 277,
      "total_tokens": 2630,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-08-04T22:43:08.094122"
  },
  {
    "ticker": "VFY",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02976851",
    "id": "02976851",
    "pages": 13,
    "price_sensitive": false,
    "date": "20250805",
    "time": "0834",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250805/pdf/06mjpty7620c8n.pdf",
    "summary": "<p>No material information identified.  </p>\n<p><em>(Note: This is a Corporate Governance Statement, which is largely a compliance document. It does not contain trading-sensitive or capital markets-related information such as financial performance, capital raising, material contracts, or operational updates impacting valuation or liquidity.)</em></p>",
    "usage": {
      "prompt_tokens": 7445,
      "completion_tokens": 55,
      "total_tokens": 7500,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-08-04T22:43:00.703462"
  },
  {
    "ticker": "VFY",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02976850",
    "id": "02976850",
    "pages": 12,
    "price_sensitive": false,
    "date": "20250805",
    "time": "0833",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250805/pdf/06mjprt97k7fc6.pdf",
    "summary": "<p><strong>Summary of ASX Announcement (Appendix 4G - Corporate Governance Disclosure):</strong>  </p>\n<ul>\n<li><strong>No material trading or capital markets information identified.</strong>  </li>\n<li>Document solely confirms compliance with ASX Corporate Governance Council principles for the period ending 30 June 2025.  </li>\n<li>Corporate governance policies and disclosures are available at <a href=\"https://vitrafy.com/investors/\">Vitrafy\u2019s investor website</a>.  </li>\n</ul>\n<p><em>Note: This is a routine governance disclosure with no immediate impact on valuation, liquidity, or capital structure.</em></p>",
    "usage": {
      "prompt_tokens": 7404,
      "completion_tokens": 108,
      "total_tokens": 7512,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-08-04T22:56:07.768718"
  },
  {
    "ticker": "VFY",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02976849",
    "id": "02976849",
    "pages": 29,
    "price_sensitive": true,
    "date": "20250805",
    "time": "0833",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250805/pdf/06mjppmrn4n3yw.pdf",
    "summary": "<p>Based on the provided ASX announcement (FY25 Financial Results Presentation), here is the concise extraction of material information:</p>\n<h3><strong>Financial Highlights (FY25)</strong></h3>\n<ul>\n<li><strong>Cash &amp; liquid assets:</strong> $29.6m ($19.5m cash + $10.1m term deposits).  </li>\n<li><strong>Revenue:</strong> Up 75% YoY to $65k (primarily from aquaculture/Huon growth).  </li>\n<li><strong>Grant income:</strong> $4.8m awarded ($2.4m received, balance deferred).  </li>\n<li><strong>R&amp;D tax incentive:</strong> $983k (down from $2.0m in FY24 due to reduced eligibility).  </li>\n<li><strong>Net loss (normalized):</strong> $(11.3)m (excluding non-cash/non-recurring items like $18.9m convertible note conversion costs).  </li>\n</ul>\n<h3><strong>Operational Highlights</strong></h3>\n<ol>\n<li><strong>Blood Platelets (U.S. Military Collaboration)</strong>  </li>\n<li>Phase 1 study completed with results exceeding industry standards.  </li>\n<li>\n<p>Phase 2 Statement of Work (SOW) to commence Q1 FY26.  </p>\n</li>\n<li>\n<p><strong>Cell &amp; Gene Therapy</strong>  </p>\n</li>\n<li>Validation data shows 96% viability vs. industry standard (70%).  </li>\n<li>\n<p>Revenue-generating collaborations under discussion.  </p>\n</li>\n<li>\n<p><strong>Aquaculture/Bovine</strong>  </p>\n</li>\n<li>Paid pilots with domestic providers; fertilization outcomes competitive vs. fresh samples.  </li>\n<li>\n<p>Global market expansion in animal reproduction pursued (e.g., Select Sires collaboration).  </p>\n</li>\n<li>\n<p><strong>Technology Development (VCU2 Hardware &amp; LifeChain Software)</strong>  </p>\n</li>\n<li>Unregulated market launch targeted H1 FY26; regulated (medical device) launch H2 FY26 (USA).  </li>\n<li>$4.8m grant secured to support commercialization.  </li>\n</ol>\n<h3><strong>FY26 Outlook</strong></h3>\n<ul>\n<li>Focus on revenue generation:  </li>\n<li>Scale U.S. operations and partnerships.  </li>\n<li>Advance blood platelets Phase 2 and human health collaborations.  </li>\n<li>Execute product launches (unregulated/regulated markets).  </li>\n</ul>\n<h3><strong>Key Non-Material Omissions</strong></h3>\n<ul>\n<li>Leadership bios, disclaimer boilerplate, and general market commentary excluded.  </li>\n</ul>\n<p><strong>Summary:</strong> Progress in commercialization, strong liquidity ($29.6m), and advancing partnerships in high-potential sectors (blood, gene therapy, aquaculture). No immediate capital raising or material structural changes noted.</p>",
    "usage": {
      "prompt_tokens": 6122,
      "completion_tokens": 483,
      "total_tokens": 6605,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-08-04T22:51:41.668098"
  },
  {
    "ticker": "CYP",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02976846",
    "id": "02976846",
    "pages": 15,
    "price_sensitive": false,
    "date": "20250805",
    "time": "0832",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250805/pdf/06mjph6w2my9vh.pdf",
    "summary": "<h3>Summary of ASX Announcement:</h3>\n<p><strong>Investor Webinar Announcement</strong><br />\n- No material trading or capital markets information disclosed.  </p>\n<p><strong>Presentation Highlights (Appendix 4C Equivalent):</strong><br />\n- <strong>Cash Runway</strong>: Secure funding until mid-2026.<br />\n- <strong>Clinical Milestones</strong>:<br />\n  - <strong>CYP-001 (aGvHD)</strong>: Phase 2 enrolment &gt;75% complete; primary results expected 1H 2026.<br />\n  - <strong>CYP-004 (Osteoarthritis)</strong>: Phase 3 enrolment complete; final results expected Feb\u2013Apr 2026; potential TGA approval pathway indicated.<br />\n  - <strong>CYP-001 (Kidney Transplantation)</strong>: Cohort 1 data review by Q4 2025.<br />\n- <strong>Preclinical Data</strong>: Positive results for heart disease treatment using MSC-derived factors.  </p>\n<p><strong>Capital Structure</strong>:<br />\n- <strong>Market Cap</strong>: ~A$38m (225m shares @ A$0.17).<br />\n- <strong>Top Holders</strong>: Top 20 shareholders own ~47% (Fidelity, BioScience Managers, Fujifilm).  </p>\n<p><strong>Catalysts</strong>:<br />\n- Three clinical trial readouts expected within FY2026 (aGvHD, osteoarthritis, kidney transplantation).  </p>\n<p><strong>No material capital-raising, trading halt, or significant liquidity/capital structure updates identified.</strong></p>",
    "usage": {
      "prompt_tokens": 3284,
      "completion_tokens": 279,
      "total_tokens": 3563,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-08-04T22:56:27.592731"
  },
  {
    "ticker": "CC5",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02976847",
    "id": "02976847",
    "pages": 6,
    "price_sensitive": false,
    "date": "20250805",
    "time": "0832",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250805/pdf/06mjpkb829ygvd.pdf",
    "summary": "<ul>\n<li><strong>Security Issuance</strong>: 3,252,326 ordinary fully paid shares (CC5) issued as part of executive team annual bonus (non-cash consideration).  </li>\n<li><strong>Post-Issuance Capital Structure</strong>:  </li>\n<li>Quoted:  <ul>\n<li>1,781,488,271 CC5 ordinary shares  </li>\n<li>385,856,694 CC5OA options (expiring 15-Nov-2025)  </li>\n</ul>\n</li>\n<li>Unquoted**: Various options/rights totalling ~132M+ securities (details in announcement).  </li>\n</ul>\n<p><strong>Note</strong>: No material trading or capital impact (non-dilutive issuance for bonuses).</p>",
    "usage": {
      "prompt_tokens": 1612,
      "completion_tokens": 134,
      "total_tokens": 1746,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-08-04T22:43:15.296841"
  },
  {
    "ticker": "CCP",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02976843",
    "id": "02976843",
    "pages": 4,
    "price_sensitive": false,
    "date": "20250805",
    "time": "0830",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250805/pdf/06mjp8n3xp554s.pdf",
    "summary": "<ul>\n<li><strong>Dividend Announcement (Appendix 3A.1)</strong>  </li>\n<li><strong>Security</strong>: CCP (Ordinary Fully Paid)  </li>\n<li><strong>Dividend Amount</strong>: AUD 0.36 per share (fully franked at 30%)  </li>\n<li><strong>Key Dates</strong>:  <ul>\n<li>Ex-Date: 15/9/2025  </li>\n<li>Record Date: 16/9/2025  </li>\n<li>Payment Date: 26/9/2025  </li>\n</ul>\n</li>\n<li><strong>Financial Period</strong>: Relates to 6 months ending 30/6/2025  </li>\n</ul>\n<p>No other material information identified.</p>",
    "usage": {
      "prompt_tokens": 1212,
      "completion_tokens": 126,
      "total_tokens": 1338,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-08-04T22:56:03.906771"
  },
  {
    "ticker": "CCP",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02976844",
    "id": "02976844",
    "pages": 13,
    "price_sensitive": false,
    "date": "20250805",
    "time": "0830",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250805/pdf/06mjpbs23z99yx.pdf",
    "summary": "<p>This is an <strong>Appendix 4G</strong> disclosure, which is a <strong>corporate governance compliance document</strong>. It does not contain material trading or capital markets information.  </p>\n<p><strong>Key takeaway</strong>:<br />\n- No material information identified for trading or capital markets decisions.  </p>\n<p><em>(Appendix 4G is a routine administrative filing verifying governance compliance, not a market-sensitive announcement.)</em></p>",
    "usage": {
      "prompt_tokens": 8136,
      "completion_tokens": 74,
      "total_tokens": 8210,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-08-04T22:45:22.297814"
  },
  {
    "ticker": "TLX",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02976845",
    "id": "02976845",
    "pages": 10,
    "price_sensitive": true,
    "date": "20250805",
    "time": "0830",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250805/pdf/06mjpdy4k87wk7.pdf",
    "summary": "<h3><strong>Material Information Summary</strong></h3>\n<ul>\n<li><strong>Reporting Currency Change</strong>: Telix switched from AUD to USD as its reporting currency effective <strong>1 January 2025</strong>, aligning with its predominantly USD-denominated revenue and costs.  </li>\n<li><strong>H1 2025 OPEX Guidance</strong>: Operating expenditure (excluding R&amp;D) expected to be <strong>~36% of revenue</strong> (~$86.3M based on H1 2024 revenue). Reflects expanded operations post-RLS Radiopharmacies acquisition (completed <strong>27 January 2025</strong>).  </li>\n<li><strong>Financial Highlights (Recast, Unaudited)</strong>:  </li>\n<li><strong>H1 2024</strong>: Revenue <strong>$239.6M</strong> (up 61% YoY), gross margin <strong>66%</strong>, operating profit <strong>$27.7M</strong>.  </li>\n<li><strong>FY 2024</strong>: Revenue <strong>$516.6M</strong>, gross margin <strong>65%</strong>, operating profit <strong>$55.2M</strong>.  </li>\n<li><strong>Cash</strong>: FY 2024 closing balance <strong>$440.0M</strong> (vs. $84.3M in FY 2023), bolstered by <strong>$416.8M net financing cash inflows</strong> (incl. convertible bonds).  </li>\n<li><strong>Upcoming Catalyst</strong>: Interim results for H1 2025 to be released on <strong>21 August 2025</strong>.  </li>\n</ul>\n<p><em>No capital raising, trading halt, or exceptional operational updates identified.</em></p>",
    "usage": {
      "prompt_tokens": 7136,
      "completion_tokens": 290,
      "total_tokens": 7426,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-08-04T22:45:10.743267"
  },
  {
    "ticker": "JCS",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02976835",
    "id": "02976835",
    "pages": 3,
    "price_sensitive": false,
    "date": "20250805",
    "time": "0829",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250805/pdf/06mjnqyz9wr9xw.pdf",
    "summary": "<ul>\n<li><strong>Substantial shareholder movements</strong>: Multiple off-market trades between related entities (Gramell Holdings, Gramell Investments, Darrell Baillie, Graham Baillie) involving large blocks of shares.  </li>\n<li><strong>Key transactions</strong>:  </li>\n<li><strong>22/04/2015</strong>: Transfers totaling ~71.4m and ~1.8m shares between entities at fixed prices.  </li>\n<li><strong>23/04/2015</strong>: Reversal/offsetting trades (~36.6m shares each) at same valuation.  </li>\n<li><strong>28/08/2020</strong>: Superfund transfer of ~83.1m shares ($1.64m consideration).  </li>\n<li><strong>04/08/2025</strong>: Dilution event (20m new shares issued by JCS), no consideration for existing Baillie Superfund holding (~83.1m shares).  </li>\n</ul>\n<p><strong>Material impact</strong>: Potential overhang risk or changes in control dynamics due to concentrated ownership shifts. No capital raising or valuation-impacting operational updates.  </p>\n<p><em>(Note: Document appears to be a historical summary of shareholding changes; most recent material event is the 2025 dilution.)</em></p>",
    "usage": {
      "prompt_tokens": 884,
      "completion_tokens": 233,
      "total_tokens": 1117,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-08-04T22:47:45.609506"
  },
  {
    "ticker": "CCP",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02976840",
    "id": "02976840",
    "pages": 3,
    "price_sensitive": true,
    "date": "20250805",
    "time": "0829",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250805/pdf/06mjp2cl8nxp37.pdf",
    "summary": "<ul>\n<li><strong>FY2025 Highlights</strong>  </li>\n<li><strong>NPAT</strong>: $94.1m (+16% YoY vs. underlying NPAT of $81.2m).  </li>\n<li><strong>US Debt Buying</strong>: Collections up 12%; record FY26 pipeline of A$164m contracted.  </li>\n<li><strong>Consumer Lending</strong>: NPAT $54.3m (+31% YoY); loan book grew 5% to $466m.  </li>\n<li>\n<p><strong>Final Dividend</strong>: 36 cents/share (49% payout ratio).  </p>\n</li>\n<li>\n<p><strong>FY2026 Guidance</strong>  </p>\n</li>\n<li><strong>NPAT</strong>: $100\u2013110m (+12% at midpoint).  </li>\n<li><strong>PDL Acquisitions</strong>: $280\u2013330m (+27%).  </li>\n<li>\n<p><strong>EPS</strong>: 147\u2013162 cents (+12%).  </p>\n</li>\n<li>\n<p><strong>Key Strategic Updates</strong>  </p>\n</li>\n<li>UK consumer lending launch planned for 1H FY26.  </li>\n<li>Wizit digital credit card pilot expanded.  </li>\n<li>AU/NZ debt buying market remains constrained (-29% purchasing YoY).  </li>\n</ul>\n<p>Omitted: Operational commentary, executive quotes, and non-financial details.</p>",
    "usage": {
      "prompt_tokens": 1542,
      "completion_tokens": 236,
      "total_tokens": 1778,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-08-04T22:56:40.976232"
  },
  {
    "ticker": "JCS",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02976838",
    "id": "02976838",
    "pages": 2,
    "price_sensitive": false,
    "date": "20250805",
    "time": "0829",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250805/pdf/06mjny6zbnzgym.pdf",
    "summary": "<ul>\n<li><strong>Substantial Holder Change</strong>: Mark Jobling's voting power in JCurve Solutions Limited decreased from <strong>15.47% to 14.47%</strong> due to dilution from a <strong>20 million share issuance</strong> by JCS on 04/08/2025.  </li>\n<li><strong>Securities Held</strong>: Jobling retains <strong>50,704,301 ordinary shares</strong> (no change in holdings, dilution only).  </li>\n</ul>\n<p><em>No other material information identified.</em></p>",
    "usage": {
      "prompt_tokens": 1555,
      "completion_tokens": 94,
      "total_tokens": 1649,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-08-04T22:56:51.162797"
  },
  {
    "ticker": "CCP",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02976836",
    "id": "02976836",
    "pages": 2,
    "price_sensitive": true,
    "date": "20250805",
    "time": "0829",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250805/pdf/06mjnt1tjkcyst.pdf",
    "summary": "<ul>\n<li><strong>Revenue (FY25):</strong> AUD 545.6m (+14.6% YoY)  </li>\n<li><strong>Net Profit After Tax (FY25):</strong> AUD 94.1m (+85.6% YoY)  </li>\n<li><strong>Dividends (FY25):</strong>  </li>\n<li>Interim: 32.0 cps (100% franked, paid 28 Mar 2025)  </li>\n<li>Final: 36.0 cps (100% franked, declared but unpaid at 30 Jun 2025)  </li>\n<li><strong>Net Tangible Assets (NTA) per share:</strong> AUD 12.86 (vs. AUD 11.55 in FY24)  </li>\n<li><strong>Closing cash balance:</strong> Not disclosed (refer to Annual Report)  </li>\n</ul>\n<p><em>Note: Additional operational/financial details likely in linked reports (Media Release, Annual Report), but not provided in this extract.</em></p>",
    "usage": {
      "prompt_tokens": 1034,
      "completion_tokens": 186,
      "total_tokens": 1220,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-08-04T22:50:47.112268"
  },
  {
    "ticker": "TPG",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02976841",
    "id": "02976841",
    "pages": 31,
    "price_sensitive": true,
    "date": "20250805",
    "time": "0829",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250805/pdf/06mjp4fy9ty94m.pdf",
    "summary": "<p>Here\u2019s the concise extraction of material information from the TPG Telecom ASX announcement, tailored for capital markets decisions:</p>\n<hr />\n<p><strong>Capital Management Plan Summary</strong><br />\n- <strong>Capital Reduction</strong>: Pro rata return of up to <strong>$3 billion</strong> (~$1.61/share), subject to shareholder approval at EGM (planned October 2025).<br />\n- <strong>Reinvestment Plan</strong>: Up to <strong>$688 million</strong> in new shares for minorities; if fully subscribed, free float increases to ~30% (currently 23%).<br />\n- <strong>Debt Repayment</strong>: Targeting <strong>$2.4 billion</strong> reduction (to ~$1.7bn drawn debt); pro forma leverage at <strong>1.3x EBITDA</strong> (pre-AASB16).<br />\n- <strong>Dividend Policy</strong>: <strong>18 cps</strong> targeted for FY25 (flat YoY), with growth tied to future cash flow/profits.  </p>\n<p><strong>Key Dates</strong><br />\n- <strong>1H25 Results</strong>: 28 Aug 2025.<br />\n- <strong>EGM/Record Date</strong>: October 2025 (exact TBC).<br />\n- <strong>Distribution/Issuance</strong>: Late October 2025 (post EGM).  </p>\n<p><strong>Operational Highlights (Pro Forma 1H25)</strong><br />\n- <strong>EBITDA</strong>: $786m (+0.9% YoY) on revenue of $2.45bn (+2.0% YoY).<br />\n- <strong>Mobile Subscribers</strong>: +100k (postpaid port-ins +48% YoY).<br />\n- <strong>FY25 Guidance</strong>: EBITDA $1.605\u20131.655bn; capex ~$790m (incl. LEOsat investment).  </p>\n<p><strong>Liquidity Impact</strong><br />\n- Post-Vocus sale: <strong>$4.7bn net proceeds</strong> (closing cash balance not stated).<br />\n- Free cash flow rebound expected post-peak capex (FY27 target: $550\u2013650m).  </p>\n<hr />\n<p>Notes:<br />\n- Tax ruling sought for Capital Reduction treatment.<br />\n- <strong>Material Risk</strong>: Plan hinges on EGM approval and market conditions.<br />\n- Omitted: Non-IFRS metrics, historical data, and regulatory disclaimers. No material info missing.  </p>\n<p><strong>Actionable</strong>: Watch EGM outcome (October) and 1H25 results (28 Aug) for confirmation of capital return timelines.</p>",
    "usage": {
      "prompt_tokens": 8022,
      "completion_tokens": 481,
      "total_tokens": 8503,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-08-04T22:55:52.414144"
  },
  {
    "ticker": "CCP",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02976842",
    "id": "02976842",
    "pages": 21,
    "price_sensitive": true,
    "date": "20250805",
    "time": "0829",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250805/pdf/06mjp6hq8453hb.pdf",
    "summary": "<h3><strong>FY25 Results Announcement Summary</strong></h3>\n<h4><strong>Key Financial Highlights</strong></h4>\n<ul>\n<li><strong>Revenue</strong>: $545.6m (+5% YoY)  </li>\n<li><strong>AU/NZ Debt Buying</strong>: $219.9m (-5%)  </li>\n<li><strong>US Debt Buying (pre-impairment)</strong>: $125.9m (+14%)  </li>\n<li><strong>AU/NZ Lending</strong>: $199.8m (+12%)  </li>\n<li><strong>NPAT (pre-impairment)</strong>: $94.1m (+16% YoY)  </li>\n<li><strong>Statutory NPAT</strong>: $100.7m (includes $4.5m US PPP loan forgiveness)  </li>\n<li><strong>EPS (basic)</strong>: 138.2c (+86%)  </li>\n<li><strong>Dividend</strong>: 68.0c (+79%)  </li>\n<li><strong>Cash Balance</strong>: $51.1m net operating cash flow (vs. -$50.0m in FY24)  </li>\n<li><strong>Gearing</strong>: 28.5% (net borrowings to carrying value)  </li>\n</ul>\n<h4><strong>Segment Performance &amp; Outlook</strong></h4>\n<ul>\n<li><strong>US Debt Buying</strong>:  </li>\n<li>FY26 investment guidance: <strong>$200\u2013230m</strong> (70% already contracted).  </li>\n<li>Focus on shorter-duration credit card receivables.  </li>\n<li><strong>AU/NZ Lending</strong>:  </li>\n<li><strong>Wizit digital credit card</strong> rollout (pilot book: $45m, target: $100\u2013200m medium-term).  </li>\n<li>Plans to resume auto lending growth and expand into UK sub-prime market (H1 FY26).  </li>\n<li><strong>AU/NZ Debt Buying</strong>:  </li>\n<li>Stabilized sale volumes, but competition from private credit.  </li>\n</ul>\n<h4><strong>FY26 Guidance</strong></h4>\n<ul>\n<li><strong>Ledger Investment</strong>: $280\u2013330m  </li>\n<li><strong>Gross Lending</strong>: $350\u2013390m  </li>\n<li><strong>NPAT</strong>: $100\u2013110m (+12% at midpoint)  </li>\n<li><strong>EPS</strong>: 147\u2013162c  </li>\n</ul>\n<h4><strong>Capital Position</strong></h4>\n<ul>\n<li>Excess capital: <strong>$150m</strong> available for growth.  </li>\n</ul>\n<p><strong>Omitted</strong>: Operational metrics, non-material segment details, and historical data.</p>",
    "usage": {
      "prompt_tokens": 4394,
      "completion_tokens": 448,
      "total_tokens": 4842,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-08-04T22:45:45.611113"
  },
  {
    "ticker": "TPG",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02976839",
    "id": "02976839",
    "pages": 5,
    "price_sensitive": true,
    "date": "20250805",
    "time": "0829",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250805/pdf/06mjp098wgc7ks.pdf",
    "summary": "<p><strong>Capital Raising Announcement Summary:</strong><br />\n- <strong>Capital Return</strong>: Up to <strong>$3 billion</strong> pro rata capital reduction (~<strong>$1.61/share</strong>).<br />\n- <strong>Reinvestment Plan</strong>: Up to <strong>$688 million</strong> raised from minority shareholders to increase free float (23% \u2192 30%) and repay debt.<br />\n- <strong>Debt Repayment</strong>: Total <strong>$2.4 billion</strong> (incl. Reinvestment proceeds), targeting <strong>$1.7bn</strong> residual debt (~1.3x FY25 EBITDA).<br />\n- <strong>Dividend</strong>: FY25 target <strong>18c/share</strong> (flat vs. FY24), with policy to grow payout over time.<br />\n- <strong>Key Dates</strong>: EGM for approval in <strong>early October 2025</strong>; Reinvestment Plan settles <strong>late October</strong>.  </p>\n<p><strong>Material Financial Impact</strong>:<br />\n- Post-transaction net leverage at investment-grade level.<br />\n- Strategic shareholders (77% combined) support all initiatives; no participation in Reinvestment Plan to boost free float liquidity.  </p>\n<p><strong>Note</strong>: Subject to shareholder/regulatory approvals. Reinvestment Plan pricing &amp; final terms TBD.  </p>\n<p><em>(Omitted: Tax rulings, webcast details, operational commentary, disclaimers.)</em></p>",
    "usage": {
      "prompt_tokens": 3238,
      "completion_tokens": 254,
      "total_tokens": 3492,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-08-04T22:47:27.584594"
  },
  {
    "ticker": "PNR",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02976833",
    "id": "02976833",
    "pages": 23,
    "price_sensitive": false,
    "date": "20250805",
    "time": "0828",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250805/pdf/06mjnlswh780j5.pdf",
    "summary": "<p><strong>Material Information Summary (ASX:PNR - Pantoro Limited - Diggers &amp; Dealers Presentation - August 2025)</strong>  </p>\n<ul>\n<li><strong>Cash Position &amp; Liquidity</strong>:  </li>\n<li><strong>Cash &amp; gold (30 June 2025)</strong>: A$176M (up A$72M YoY).  </li>\n<li><strong>Debt</strong>: Fully repaid; zero outstanding.  </li>\n<li>\n<p><strong>Hedging</strong>: 12,000oz put options @ A$3,500/oz; 6,000oz calls @ A$4,200/oz (expiring end-2025).  </p>\n</li>\n<li>\n<p><strong>FY2025 Operational Performance</strong>:  </p>\n</li>\n<li><strong>Production</strong>: Unspecified volume, but AISC of A$1,991/oz.  </li>\n<li><strong>EBITDA</strong>: A$196.4M (FY25).  </li>\n<li>\n<p><strong>Processing</strong>: 1.2Mtpa plant operating at 95.8% recovery.  </p>\n</li>\n<li>\n<p><strong>FY2026 Guidance</strong>:  </p>\n</li>\n<li><strong>Production</strong>: 100,000\u2013110,000oz gold.  </li>\n<li><strong>AISC</strong>: A$1,950\u2013A$2,250/oz.  </li>\n<li><strong>Exploration budget</strong>: A$55M (focus: Scotia, OK mines, Mainfield).  </li>\n<li>\n<p><strong>Growth capex</strong>: A$67M (regional exploration ramp-up).  </p>\n</li>\n<li>\n<p><strong>Key Growth Projects</strong>:  </p>\n</li>\n<li><strong>OK Underground</strong>: Steady-state production (~40,000ozpa); grade 5.83g/t (FY25).  </li>\n<li><strong>Scotia Underground</strong>: Ramping to ~60,000ozpa; high-grade extensions identified.  </li>\n<li><strong>Mainfield</strong>: High-grade drilling results (e.g., 5.7m @ 35.85g/t); Bullen decline rehabilitation underway (potential 40,000oz from 130kt @ 9.5g/t).  </li>\n<li>\n<p><strong>Open Pits</strong>: Princess Royal operational (20,000oz @ 2.1g/t in 2025); Gladstone pit to start 2026.  </p>\n</li>\n<li>\n<p><strong>Resource Base</strong>:  </p>\n</li>\n<li>\n<p><strong>Total M&amp;I Resources</strong>: 44.9Mt @ 3.3g/t (4.7Moz Au) (per 26 Sep 2024 statement; no material changes).  </p>\n</li>\n<li>\n<p><strong>Market Position</strong>:  </p>\n</li>\n<li><strong>Market Cap</strong>: A$1.4B (share price A$3.66 as of 31 July 2025).  </li>\n<li><strong>Major Shareholders</strong>: Tulla (12.7%), Regal FM (12.3%), Sprott (7.2%).  </li>\n</ul>\n<p><strong>Key Catalyst</strong>:<br />\n- <strong>Mainfield development</strong> (potential to double production to +200kozpa medium-term).  </p>\n<p><em>No capital raising, trading halt, or other material corporate actions announced.</em></p>",
    "usage": {
      "prompt_tokens": 7566,
      "completion_tokens": 588,
      "total_tokens": 8154,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-08-04T22:50:17.737028"
  },
  {
    "ticker": "TPG",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02976834",
    "id": "02976834",
    "pages": 6,
    "price_sensitive": true,
    "date": "20250805",
    "time": "0828",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250805/pdf/06mjnnw43r7z1q.pdf",
    "summary": "<h3><strong>Material Information Summary</strong></h3>\n<h4><strong>Pro Forma FY25 Guidance</strong></h4>\n<ul>\n<li><strong>Pro Forma EBITDA</strong>: $1,605M \u2013 $1,655M (Statutory EBITDA ~$35M higher due to 5-month inclusion of new commercial arrangements).  </li>\n<li><strong>Pro Forma Capex (ex-spectrum)</strong>: ~$790M (includes $20M incremental spend on LEOsat infrastructure and EGW Mobile IT upgrades).  </li>\n</ul>\n<h4><strong>Vocus Transaction Impact</strong></h4>\n<ul>\n<li>Discontinued Operations (sold assets) excluded from Pro Forma financials; new commercial arrangements (wholesale/lease agreements) reflected.  </li>\n</ul>\n<h4><strong>Key Pro Forma Financial Trends (FY23 \u2192 FY24)</strong></h4>\n<ul>\n<li><strong>Revenue</strong>: Flat at $4,904M (Pro Forma).  </li>\n<li><strong>EBITDA (guidance basis)</strong>: +6.1% to $1,600M (Pro Forma).  </li>\n<li><strong>Operating Cash Flow</strong>: +39.4% to $1,546M (Pro Forma).  </li>\n</ul>\n<h4><strong>Balance Sheet (Post-Vocus, 1 Aug 2025)</strong></h4>\n<ul>\n<li><strong>Lease Liabilities</strong>: Increase to $2.8B ($2.6B non-current, $0.19B current).  </li>\n</ul>\n<h4><strong>No Capital Raising or Trading Halt Requested</strong>.</h4>\n<p><strong>Note</strong>: Guidance assumes stable operating conditions and excludes one-offs. Statutory reporting for 1H25/FY25 will exclude Discontinued Operations but not Vocus-related commercial impacts pre-31 July 2025.</p>",
    "usage": {
      "prompt_tokens": 3176,
      "completion_tokens": 320,
      "total_tokens": 3496,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-08-04T22:50:30.120288"
  },
  {
    "ticker": "ADX",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02976754",
    "id": "02976754",
    "pages": 2,
    "price_sensitive": false,
    "date": "20250805",
    "time": "0818",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250805/pdf/06mjh94b74ffk3.pdf",
    "summary": "<ul>\n<li><strong>Change of Director\u2019s Interest Notice (Appendix 3Y)</strong>  </li>\n<li><strong>Director</strong>: Edouard Etienvre  </li>\n<li><strong>Securities Acquired</strong>:  <ul>\n<li><strong>Direct</strong>: 112,069 Fully Paid Ordinary Shares (part of director fees).  </li>\n<li><strong>Indirect</strong>: 290,948 Fully Paid Ordinary Shares (part of consulting fees).  </li>\n</ul>\n</li>\n<li><strong>Total Holdings After Change</strong>:  <ul>\n<li><strong>Direct</strong>: 1,046,038 shares.  </li>\n<li><strong>Indirect</strong>: 5,167,767 shares (held via NGX Commodities Ltd).  </li>\n</ul>\n</li>\n<li><strong>Nature of Change</strong>: Issuance under ADX Directors\u2019 Share Plan (approved 22 May 2025), based on Q2 2025 fees and quarterly VWAP.  </li>\n<li><strong>No closed period trading</strong>.  </li>\n</ul>\n<p><strong>No material trading or capital markets impact identified</strong> (routine director share plan participation).</p>",
    "usage": {
      "prompt_tokens": 1098,
      "completion_tokens": 192,
      "total_tokens": 1290,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-08-04T22:19:58.212583"
  },
  {
    "ticker": "PRU",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02976755",
    "id": "02976755",
    "pages": 6,
    "price_sensitive": false,
    "date": "20250805",
    "time": "0818",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250805/pdf/06mjhc7q2gx627.pdf",
    "summary": "<ul>\n<li><strong>Type of Buy-back</strong>: On-market  </li>\n<li><strong>Total Shares Bought Back (Cumulative)</strong>: 22,995,853 (+55,694 on previous day)  </li>\n<li><strong>Total Consideration Paid (Cumulative)</strong>: AUD 72.96M (+AUD 186,574 on previous day)  </li>\n<li><strong>Price Range</strong>: Highest \u2013 AUD 3.86 (16/6/2025), Lowest \u2013 AUD 2.46 (14/11/2024)  </li>\n<li><strong>Remaining Buy-back Capacity</strong>: 16,948,183 shares (out of 40M maximum)  </li>\n<li><strong>Key Dates</strong>: Buy-back period from 24/9/2024 to 28/8/2025</li>\n</ul>",
    "usage": {
      "prompt_tokens": 1508,
      "completion_tokens": 153,
      "total_tokens": 1661,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-08-04T22:20:02.771339"
  },
  {
    "ticker": "SKO",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02976753",
    "id": "02976753",
    "pages": 2,
    "price_sensitive": false,
    "date": "20250805",
    "time": "0730",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250805/pdf/06mjgx05xf4bq0.pdf",
    "summary": "<ul>\n<li><strong>Director Share Sale</strong>: Robert Clyde McConaghy (previous director) sold <strong>10,000 ordinary shares</strong> in Serko Limited on-market.  </li>\n<li><strong>Sale Details</strong>: Price: <strong>NZ$2.86/share</strong> | Date: <strong>30 July 2025</strong>.  </li>\n<li><strong>Post-Sale Holding</strong>: <strong>143,003 shares</strong> held via Portofino Trust (previously 153,003).  </li>\n</ul>\n<p><em>No material impact on capital structure or liquidity identified\u2014routine disclosure.</em></p>",
    "usage": {
      "prompt_tokens": 1039,
      "completion_tokens": 101,
      "total_tokens": 1140,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-08-04T22:19:50.796825"
  }
]